Dosing | Vial cohort (A) | PFS cohort (B) | p values | ||
---|---|---|---|---|---|
Summary | n | Summary | n | A vs. B | |
All respondents | |||||
SCIg dose (g/week) (median [IQR]) | 12 [9, 16] | 63 | 10 [8, 12] | 110 | 0.02 |
SCIg dose per bodyweight (g/week/kg) (median [IQR]) | 0.15 [0.11, 0.19] | 56 | 0.13 [0.10, 0.17] | 100 | 0.06 |
Pump subgroup | |||||
SCIg dose (g/week) (median [IQR]) | 12 [10, 14] | 37 | 10 [8, 16] | 37 | 0.30 |
SCIg dose per bodyweight (g/week/kg) (median [IQR]) | 0.15 [0.12, 0.19] | 32 | 0.15 [0.11, 0.20] | 34 | 0.66 |
Manual push subgroup | |||||
SCIg dose (g/week) (median [IQR]) | 10 [8, 16] | 26 | 10 [8, 12] | 73 | 0.18 |
SCIg dose per bodyweight (g/week/kg) (median [IQR]) | 0.14 [0.11, 0.30] | 24 | 0.12 [0.10, 0.16] | 66 | 0.14 |